Rina-S Study for Lung Cancer

This study looks at how well Rina-S works for people with non-small cell lung cancer (NSCLC). NSCLC is a type of lung cancer that doesn't grow small, round cells. The study includes about 240 people from different countries. Everyone in the study will get the real medicine, Rina-S, and not a placebo (a fake treatment). Rina-S will be given alone, without other treatments.

Participants might stay in the study for around 12 months. They need to visit the clinic 1 to 5 times every 3 weeks for check-ups and tests like blood tests and X-rays. These are to make sure the medicine is safe and working well. If the cancer does not get worse and there are no major problems, they can stay in the study while it continues.

• Participants will be in the study for about a year.
• 1 to 5 clinic visits every 3 weeks are needed.
• No placebo; everyone gets the actual treatment.